Harbor:Sepsis antibiotics: Difference between revisions

Line 146: Line 146:


==Source==
==Source==
8/16/13 Dr. Spellberg, Uptodate, Harbor-UCLA Antibiotics Review Committee (Rev. 07/27/06)
<references/>
<references/>


[[Category:Airway/Resus]]
[[Category:Drugs]]
[[Category:Drugs]]
[[Category:ID]]
[[Category:ID]]
[[Category:Admin]]
[[Category:Admin]]

Revision as of 15:14, 23 June 2015

Unknown Source[1]

Pneumonia

Community Acquired Pneumonia (CAP)

MCC by S. pneumoniae. In young must cover for mycoplasma and other atypicals. See Pneumonia (Pathogens)

Treatment based on Pneumonia (Port Score)

  1. Mild/outpatient PNA(Port I/II):
    1. Macrolide or doxycycline alone (Save quinolone for sicker pts):
      1. Azithromycin 500mg PO Qday x 5 days OR
      2. Clarithromycin 500mg PO BID x 5 days OR
      3. Doxycycline 100mg PO BID x 7 days
  2. Hospitalized ward patients (PORT III):
    1. Beta-lactam + macrolide OR doxycycline (quinolone ok, but save for sick pt):
      1. Ceftriaxone 1 gm IV Qday + Azithromycin 500 mg IV Qday OR Doxycycline 100mg IV BID
      2. If cephalosporin allergy:
        1. Moxifloxacin 400 mg IV Qday OR Levofloxacin 750mg IV Qday
  3. PCU/ICU pts w/o RF for Pseudomonas or MRSA:
    1. Beta-lactam + macrolide OR Quinolone (Save for sick pts if possible). Quinolone monotheraphy not acceptable for these pts:
      1. Ceftriaxone 1 gm IV Qday + Azithromycin 500 mg IV Qday OR Levofloxacin 750mg IV Qday
  4. PCU/ICU pts w/RF for Pseudomonas:
    1. Cefepime 2g IV Q8H + Levofloxacin 750mg IV Qday

Healthcare Associated PNA (HCAP) + Hospital Associated PNA (HAP)

HAP occurs if pt develops PNA 2-3 days after hospitalization. HCAP occus in non-hospitalized pt with extensive healthcare contact.

  1. Mild HAP/HCAP no recent abx exposure:
    1. Cefepime 2g IV Q8H +/- Clindamycin 600mg IV OR Metronidazole
  2. Moderate HAP/HCAP or necrotizing PNA:
    1. Add Vancomycin for MRSA
    2. If shock, recent ABX, or from SNF/ward:
      1. Add Meropenem
  3. Cephalosporin allergy:
    1. Clinda 600 mg IV
    2. Cipro 400 mg IV
    3. Gentamicin 5-7 mg/kg IV

Abdominal/Pelvic

  1. Comm. Acquired
    1. Ceftriaxone 1 g IV
    2. Metronidazole 1.5 g IV
    3. Gentamicin 5-7 mg/kg IV
  2. Healthcare Assoc.
    1. Ceftazidime 2 g IV
    2. Gentamicin 5 mg/kg IV
    3. Metronidazole 1.5 mg IV
  3. Cephalosporin allergy
    1. Cipro 400 mg IV
    2. Metronidazole 1.5 g IV
    3. Gentamicin 5-7 mg/kg IV

Urosepsis

  1. Comm. Acquired
    1. Ceftriaxone 1 g IV
    2. Gentamicin 5-7 mg/kg IV
  2. Healthcare Assoc.
    1. Vancomycin 1 g IV
    2. Ceftazidime 1g IV
    3. Gentamicin 5-7 mg/kg IV
  3. Cephalosporin allergy
    1. Vancomycin 1g IV
    2. Cipro 400 mg IV
    3. Gentamicin 5 mg/kg IV

Meningitis (Nl/Community)

  1. Comm. Acquired
    1. Ceftriaxone 2 g IV
    2. Add Vancomycin 1 g IV if CSF Results suggest pneumococcal meningitis (for ceftriaxone resistant S. pneumoniae)
    3. Add Ampicillin 2g IV Q4H in age >50 years and pregnant
  2. Cephalosporin allergy
    1. Chloramphenicol 1 g IV
    2. Vancomycin 1.5g IV

Meningitis (Nl/Post neurosurgical)

  1. Healthcare Assoc.
    1. Vancomycin 1.5 g IV
    2. Cefepime 2 g IV
  2. Cephalosporin allergy
    1. Vancomycin 1.5g IV
    2. Cipro 400mg IV

Meningitis (Immunocomp)

(Cirrhosis, EtoH, age > 65, steroids, HIV)

  1. Comm. Acquired
    1. Penicillin G 4M Units IV
    2. Ceftriaxone 2 g IV
    3. Vancomycin 1g IV
  2. Cephalosporin allergy
    1. Chloramphenicol 1g IV
    2. Trim/sulfa 10mg/kg IV
    3. Vancomycin 1.5g IV

Necrotizing Soft-tissue Infection

  1. Comm. Acquired/Healthcare Assoc.
    1. Vancomycin 1 gm IV
    2. Ceftriaxone 1 gm IV
    3. Clinda 600 mg IV
    4. Consider: Gent 5-7mg/k IV
  2. Healthcare Assoc.
    1. Vancomycin 1g IV
    2. Piperacillin/Tazobactam 3.375g IV
    3. Clindamycin 600mg IV
  3. Cephalosporin allergy
    1. Vancomycin 1 gm IV
    2. Clinda 600 mg IV
    3. Cipro 400 mg IV
    4. Gentamicin 5-7mg/kg

Neutropenic Fever

  • Severe Sepsis
    • Cefepime 2 g IVPB x 1
    • Vancomycin 1 g IVPB x 1
  • Septic Shock

See Also

Source

  1. Form v2011.09.15